期刊
HUMAN VACCINES & IMMUNOTHERAPEUTICS
卷 17, 期 1, 页码 14-21出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2020.1757989
关键词
Immune system; immune tolerance; self-antigen; vaccine; cancer; autoimmune disease; alphavirus; sv40; adeno-associated virus; lentivirus; viral vector; gene therapy; immunotherapy; tolerization
资金
- Amarna Therapeutics B.V.
Viruses are efficient gene delivery vectors for therapies, with replication competent and defective vectors inducing strong immune responses for cancer treatments and genetic disorder therapies. Different viral vectors have applications in various disease treatments and pathogenesis studies.
Viruses have evolved to efficiently express their genes in host cells, which makes them ideally suited as gene delivery vectors for gene and immunotherapies. Replication competent (RC) viral vectors encoding foreign or self-proteins induce strong T-cell responses that can be used for the development of effective cancer treatments. Replication-defective (RD) viral vectors encoding self-proteins are non-immunogenic when introduced in a host naive for the cognate virus. RD viral vectors can be used to develop gene replacement therapies for genetic disorders and tolerization therapies for autoimmune diseases and allergies. Degenerative/inflammatory diseases are associated with chronic inflammation and immune responses that damage the tissues involved. These diseases therefore strongly resemble autoimmune diseases. This review deals with the use of RC and RD viral vectors for unraveling the pathogenesis of immune-related diseases and their application to the development of the next generation prophylactics and therapeutics for todays' major diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据